The promise and challenges of drug repurposing in psychiatry

被引：30

作者：

Fava, Maurizio ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA

来源：

WORLD PSYCHIATRY | 2018年 / 17卷 / 01期

关键词：

EFFICACY;

D O I：

10.1002/wps.20481

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：28 / 29

页数：2

共 9 条

[1]

Bear L., 2013, CLIN INVESTIGATION, V3

[2] A DOUBLE-BLIND PLACEBO CONTROLLED-STUDY OF DESIPRAMINE IN THE TREATMENT OF ADD .1. EFFICACY [J].

BIEDERMAN, J ;

BALDESSARINI, RJ ;

WRIGHT, V ;

KNEE, D ;

HARMATZ, JS .

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1989, 28 (05) :777-784

[3]

Caban A, 2017, J Mark Access Health Policy, V5, P1299833, DOI 10.1080/20016689.2017.1299833

[4]

Ferry L, 2003, INT J CLIN PRACT, V57, P224

[5] Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies [J].

Griffiths, Christopher E. M. ;

Fava, Maurizio ;

Miller, Andrew H. ;

Russell, James ;

Ball, Susan G. ;

Xu, Wen ;

Acharya, Nayan ;

Rapaport, Mark Hyman .

PSYCHOTHERAPY AND PSYCHOSOMATICS, 2017, 86 (05) :260-267

[6] Evergreening, patent challenges, and effective market life in pharmaceuticals [J].

Hemphill, C. Scott ;

Sampat, Bhaven N. .

JOURNAL OF HEALTH ECONOMICS, 2012, 31 (02) :327-339

[7]

Lempérière T, 2001, ENCEPHALE, V27, P365

[8]

Murteira Susana, 2013, J Mark Access Health Policy, V1, DOI 10.3402/jmahp.v1i0.21131

[9] An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder [J].

Spencer, T ;

Biederman, J ;

Heiligenstein, J ;

Wilens, T ;

Faries, D ;

Prince, J ;

Faraone, SV ;

Rea, J ;

Witcher, J ;

Zervas, S .

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2001, 11 (03) :251-265

← 1 →